3D Bioprinting Market: Growth, Size, Share, and Trends

3D Bioprinting Market by Component (3D bioprinters (Microextrusion, Inkjet, Laser), Bioinks, Software, Consumable), Material (Hydrogels, ECM), Application (Research (Regenerative Medicine, 3D cell Culture), Clinical (Skin, Bone)) - Global Forecast to 2029

Report Code: BT 4971 May, 2024, by marketsandmarkets.com

Market Growth Outlook Summary

The global 3D bioprinting market growth forecasted to transform from USD 1.3 billion in 2024 to USD 2.4 billion by 2029, driven by a CAGR of 12.7%. The market growth is fueled by growing adoption of 3D bioprinting technology in the pharmaceutical and cosmetic industries, technological advancement in the 3D bioprinting and rising demand for organ transplants.

3D bioprinting Market Trends

3D bioprinting Market

To know about the assumptions considered for the study, Request for Free Sample Report

3D bioprinting Market

Global 3D bioprinting market Dynamics

Driver: Growing adoption of 3D bioprinting technology within the pharmaceutical and cosmetic industries

Increasing adoption of 3D bioprinting technology in the pharmaceutical industry has catalyzed substantial growth in the market. This innovative technology enables the precise fabrication of tissues and organs, offering pharmaceutical & biotechnology companies unprecedented opportunities for drug testing, disease modeling, and personalized medicine development. By accurately replicating the complex structures of human tissues, 3D bioprinting allows for more reliable preclinical testing, reducing the need for animal models and accelerating the drug development process. Moreover, it helps create patient-specific organ models for studying diseases and developing tailored treatments, thereby fostering advancements in precision medicine. cosmetology industry, companies leverage bioprinted skin tissue models to conduct more precise evaluations of the safety and efficacy of skincare products. These models replicate the structure and function of human skin, providing an authentic platform to evaluate how products interact with skin cells, tissues, and microbiota. By utilizing bioprinted skin models, companies can streamline product development processes, reduce reliance on animal testing, and ensure that their products adhere to rigorous safety standards while delivering optimal results for consumers. For instance, in June 2023, BICO Group AB (Sweden) Group, which includes CELLINK, Dispendix, ABM, and Sartorius (Germany), entered into a sub-sales and distribution agreement under which Sartorius distributed a range of instruments such as CELLINK’s 3D bioprinting portfolio: BIO X, BIO X6 and BIONOVA X, Dispendix’ liquid handling platform I.DOT MINI, and a wide range of bioinks and reagents from Advanced BioMatrix ( ABM) to their customers in the Asia Pacific.

Restraint: High cost of 3D bioprinters and bioinks

The high cost of 3D bioprinting poses a significant challenge to its widespread adoption and accessibility. This cutting-edge technology, which holds immense promise in revolutionizing healthcare and regenerative medicine, requires sophisticated equipment, specialized materials, and skilled expertise, all of which contribute to its hefty price tag. For example, 3D bioprinters are highly precise machines that use complex designs and advanced systems to accurately place biological materials layer by layer. These printers can cost hundreds of thousands to millions of dollars because of their sophisticated design. Creating the bioinks used in printing, which contain living cells and special materials, requires a lot of research and special processes to make sure they are efficient and safe for the human body

Opportunity: Rising demand for organ transplants

As chronic conditions, such as diabetes, hypertension, and kidney disease, have become more prevalent worldwide, the number of patients requiring organ transplantation continues to rise. These chronic diseases can lead to organ failure or irreversible damage, necessitating life-saving transplant procedures to improve patient outcomes and quality of life. For instance, as of March 2024, there are currently over 103,000 people on the national transplant waiting list and every 8 minutes, another person is added to the list; over 17 people die every year waiting for organ transplants. Similarly, as per the data released by the United Network for Organ Sharing, the number of transplants performed in the US has increased annually, with more than 46,000 organ transplants performed in 2023. Likewise, the number of registrants for organ donation reached 6.7 million in 2023 from 1,087 in 2010 in China

Challenge: Biocompatibility issues and rigorous sterilization protocols

Ensuring biocompatibility is a paramount concern in the field of 3D bioprinting, crucial for seamlessly integrating constructs into living tissues while mitigating potential adverse reactions. This begins with careful material selection, favoring natural polymers and synthetic compounds, which emulate tissue properties while minimizing immunogenicity and toxicity risks. The formulation of bioinks, containing cells within a hydrogel matrix, is pivotal for supporting optimal cell viability, proliferation, and differentiation throughout the printing process.

Biocompatibility issues can also result in organ rejection if the transplanted organ is incompatible with the recipient's body. This occurs when the recipient's immune system identifies the transplanted tissue as foreign and triggers an immune response against it, targeting specific surface proteins known as antigens. Consequently, antibodies are produced, and immune cells are activated to attack and damage the transplanted tissue. This rejection process can occur acutely, shortly after transplantation, or chronically over an extended period. According to the National University Centre for Organ Transplantation at the National University Hospital (NUH), between 30 to 40% of kidney transplants are lost over time to rejection. Addressing biocompatibility concerns is crucial in transplantation to mitigate the risk of rejection and ensure the long-term success of the transplant

3D bioprinting Market Ecosystem

3D bioprinting Market Ecosystem

The 3D bioprinter segment is projected to hold the 3D bioprinting industry dominant position during the forecast period.

Based on component, the 3D bioprinting market is divided into various segments: 3D bioinks, bioprinters, software, and consumables. The 3D bioprinters is segmented into, inkjet 3D bioprinters, laser-assisted bioprinters, magnetic 3D bioprinters, Microextrusion bioprinters, stereolithography-based bioprinters, and other 3D bioprinters (microvalve bioprinters and tissue fragment bioprinters). The bioin segment is also subdidvided into synthetic, natural and hyrdid bioinks. The 3D bioprinters segment anticipated to account highest share in the market in 2023. lucrative demand for organ transplants coupled with innovation in 3D bioprinting technology serves as driving factor in the market.

North America was the largest regional market for 3D bioprinting industry for both (excluding & including COVID -19 3D bioprinting) in 2023.

The market is segmented into five major regions namely, North America, Europe, the Asia Pacific, Latin America, Middle East and Africa. In 2023, North America accounted for the largest share of the 3D bioprinting market and expected to retain dominance throughout the forecast period of 2024-2029. Favorable regulatory policies, reimbursement scenario, presence of key market players in the region are some of the major factors uplifting the market growth in the North America. Europe is likely to grow at significant CAGR owing to various factors such as advancements in bioprinting research and development, increasing healthcare expenditure and government initiatives aimed at expanding 3D bioprinting.

3D bioprinting Market by Region

To know about the assumptions considered for the study, download the pdf brochure

Key players in the market include BICO Group AB (Sweden), 3D Systems Inc. (US), Merck KGaA (Germany), Organovo Holdings Inc (US), Collplant Biotechnologies Ltd. (Israel), regenHU (Switzerland), Aspect Biosystem Ltd. (Canada), Advanced Solutions Life Sciences, LLC (US), Cyfuse Biomedical K.K (Japan), Rokit Healthcare Inc. (South Korea), Hangzhou Genofei Biotechnology Co., Ltd. (China), Foldink (Armenia), Brinter (US), 3D bioprinting solution (Russia), REGEMAT 3D, SL (Spain), Ροietis (France), Sunp Biotech (US), GeSim – Gesellschaft Für Silizium-Mikrosysteme Mbh (Germany), Medprin (China), Voxcell Bioinnovation Inc. (Canada), Prodways (France), Inventia Life Science Pty Ltd (Australia), Upnano Gmbh (Austria), UPM (Finland), and Tissuelabs (Switzerland)

3D Bioprinting Market Report Scope

Report Metric

Details

Market Revenue in 2024

$1.3 billion

Projected Revenue by 2029

$2.4 billion

Revenue Rate

Poised to Grow at a CAGR of 12.7%

Market Driver

Growing adoption of 3D bioprinting technology within the pharmaceutical and cosmetic industries

Market Opportunity

Rising demand for organ transplants

This report categorizes the 3D bioprinting market to forecast revenue and analyze trends in each of the following submarkets:

By Component

  • 3D Bioprinters
    • Microextrusion Bioprinters
    • Inkjet 3D Bioprinters
    • Laser-Assisted Bioprinters
    • Stereolithography-Based Bioprinters
    • Magnetic 3D Bioprinters
    • Other 3D Bioprinters
  • Bioinks
    • Natural Bioinks
    • Hybrid Bioinks
    • Synthetic Bioinks
  • Software
  • Consumables

By Material

  • Living Cells
  • Hydrogels
  • Extracellular Matrices
  • Other Materials

By Application

By End User

  • Academic & Research Institutes
  • Pharmaceutical & Biotechnology Companies
  • Hospitals

By Region

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Rest of Europe (ROE)
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • RoLATAM
  • Middle East
    • GCC
      • Saudi Arabia (KSA)
      • United Arab Emirates (UAE)
      • Rest of GCC
    • Rest of Middle East
  • Africa

Recent Developments of 3D Bioprinting Market

  • In February 2024, BICO Group AB (Cellink) launched DNA Studio 4 Vault, a bioprinting software, providing users with confidence and trust in their documentation, enabling a faster translation from the research lab to the clinic
  • In February 2024, Merck KGaA (Germany) established a distribution center in Brazil with an investment of USD 21.7 million to better serve its Life Science customers for faster deliveries in the region.
  • In April 2023, Aspect Biosystem Ltd (Canada) and Novo Nordisk (Denmark) entered into a collaboration, development, and Licence agreement to develop bioprinted tissue therapeutics designed to replace, repair, or supplement biological functions inside the body to deliver a new class of truly disease-modifying treatments for diabetes and obesity.
  • In April 2023, CollPlant Biotechnologies Ltd (Israel) and Stratasys (US) entered into a collaboration for the development of collaborated to develop a solution to bio-fabricate human tissues and organs using Stratasys’ P3 technology-based bioprinter and CollPlant’s rh-Collagen-based bioinks

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.

INTRODUCTION
37
RESEARCH METHODOLOGY
42
EXECUTIVE SUMMARY
54
PREMIUM INSIGHTS
59
MARKET OVERVIEW
63
  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    DRIVERS
    - Growing adoption of 3D bioprinting in pharmaceutical and cosmetic industries
    - Technological advancements in 3D bioprinting
    - Increasing number of public-private partnerships
    - Rising investments in medical device R&D
    RESTRAINTS
    - Risk of 3D bioprinting failures
    - High cost of 3D bioprinters and bioinks
    OPPORTUNITIES
    - Rising demand for organ transplants
    - Growing demand for regenerative medicine and stem cell research
    CHALLENGES
    - Biocompatibility issues and rigorous sterilization protocols
    - Ethical concerns related to use of 3D-bioprinted products
  • 5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
  • 5.4 TECHNOLOGY ANALYSIS
    KEY TECHNOLOGIES
    - Extrusion-based bioprinting
    - Inkjet-based bioprinting
    - Stereolithography bioprinting
    COMPLEMENTARY TECHNOLOGIES
    - Microfluidics and microfabrication
    - Nanotechnology and nanomaterials
    ADJACENT TECHNOLOGIES
    - 3D scanning and imaging
    - Organ-on-a-chip
    - Organoids technology
  • 5.5 PRICING ANALYSIS
    AVERAGE SELLING PRICE OF COMPONENTS, BY REGION
  • 5.6 VALUE CHAIN ANALYSIS
  • 5.7 SUPPLY CHAIN ANALYSIS
  • 5.8 ECOSYSTEM ANALYSIS
    3D BIOPRINTER VENDORS
    BIOINK VENDORS
    END USERS
    REGULATORY BODIES
  • 5.9 PATENT ANALYSIS
    METHODOLOGY
    NUMBER OF PATENTS APPLIED AND GRANTED, BY DOCUMENT TYPE, 2014–2024
    INNOVATION AND PATENT APPLICATION
    TOP TEN PLAYERS WITH HIGHEST NUMBER OF PATENT APPLICATIONS
  • 5.10 TRADE ANALYSIS
    IMPORT DATA FOR INK-JET PRINTING MACHINES (HS CODE: 844351)
    EXPORT DATA FOR INK-JET PRINTING MACHINES (HS CODE: 844351)
    IMPORT DATA FOR PRINTERS, COPYING MACHINES, AND FACSIMILE MACHINES, WHETHER OR NOT COMBINED (HS CODE: 844339)
    EXPORT DATA FOR PRINTERS, COPYING MACHINES, AND FACSIMILE MACHINES, WHETHER OR NOT COMBINED (HS CODE: 844339)
  • 5.11 KEY CONFERENCES AND EVENTS, 2024–2025
  • 5.12 REGULATORY LANDSCAPE
    CDRH REGULATIONS ON 3D BIOPRINTING
    LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 5.13 INVESTMENT AND FUNDING SCENARIO
  • 5.14 PORTER’S FIVE FORCES ANALYSIS
    THREAT OF NEW ENTRANTS
    THREAT OF SUBSTITUTES
    BARGAINING POWER OF BUYERS
    BARGAINING POWER OF SUPPLIERS
    INTENSITY OF COMPETITIVE RIVALRY
  • 5.15 KEY STAKEHOLDERS AND BUYING CRITERIA
    KEY STAKEHOLDERS IN BUYING PROCESS
    KEY BUYING CRITERIA
    - Key buying criteria for top three end users
3D BIOPRINTING MARKET, BY COMPONENT
102
  • 6.1 INTRODUCTION
  • 6.2 3D BIOPRINTERS
    MICRO EXTRUSION BIOPRINTERS
    - Adaptability to different biomaterial types to fuel segment growth
    INKJET 3D BIOPRINTERS
    - High cell viability and low cost to propel market growth
    LASER-ASSISTED BIOPRINTERS
    - Higher resolution and better formation of 3D structures to augment segment growth
    STEREOLITHOGRAPHY-BASED BIOPRINTERS
    - Better printing quality, speed, and cell viability to aid growth
    MAGNETIC 3D BIOPRINTERS
    - Improved accuracy and speed in cultured tissue formation and processing to fuel segment growth
    OTHER 3D BIOPRINTERS
  • 6.3 BIOINKS
    NATURAL BIOINKS
    - Increasing investment in R&D and product developments to drive market
    HYBRID BIOINKS
    - Higher mechanical strength and greater biocompatibility to boost segment growth
    SYNTHETIC BIOINKS
    - Flexibility, control, and consistency to aid segment growth
  • 6.4 SOFTWARE
    INCREASING INNOVATIONS AND ADVANCEMENTS TO PROPEL SEGMENT GROWTH
  • 6.5 CONSUMABLES
    NEED FOR PRECISE BIOINK DEPOSITION FOR INTRICATE TISSUE STRUCTURES TO DRIVE MARKET
3D BIOPRINTING MARKET, BY MATERIAL
156
  • 7.1 INTRODUCTION
  • 7.2 LIVING CELLS
    INCREASED VIABILITY AND TECHNOLOGICAL ADVANCEMENTS TO AUGMENT MARKET GROWTH
  • 7.3 HYDROGELS
    INCREASING INVESTMENTS AND FUNDING TO BOOST MARKET GROWTH
  • 7.4 EXTRACELLULAR MATRICES
    INCREASED FOCUS ON R&D AND ADVANCEMENTS IN TISSUE ENGINEERING TO SUPPORT MARKET GROWTH
  • 7.5 OTHER MATERIALS
3D BIOPRINTING MARKET, BY APPLICATION
175
  • 8.1 INTRODUCTION
  • 8.2 RESEARCH APPLICATIONS
    DRUG RESEARCH
    - Better precision and greater customization facilities in pharmaceutical sector to drive segment
    REGENERATIVE MEDICINE
    - Growing demand for organ transplants to support segment growth
    3D CELL CULTURE
    - Rising investments in cell culture development to augment segment growth
  • 8.3 CLINICAL APPLICATIONS
    SKIN
    - Rising applications in skincare and cosmetics to propel segment growth
    BONE & CARTILAGE
    - Increasing incidence of musculoskeletal conditions to support segment growth
    BLOOD VESSELS
    - Growing focus on research activities to aid segment growth
    OTHER CLINICAL APPLICATIONS
3D BIOPRINTING MARKET, BY END USER
213
  • 9.1 INTRODUCTION
  • 9.2 ACADEMIC & RESEARCH INSTITUTES
    RISING GOVERNMENT FUNDING AND INCREASING NUMBER OF INDUSTRY-ACADEMIA COLLABORATIONS TO DRIVE MARKET
  • 9.3 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
    INCREASING PREVALENCE OF CHRONIC DISEASES TO PROPEL MARKET GROWTH
  • 9.4 HOSPITALS
    RISING NUMBER OF STRATEGIC PARTNERSHIPS WITH BIOTECHNOLOGY COMPANIES TO AID MARKET GROWTH
3D BIOPRINTING MARKET, BY REGION
228
  • 10.1 INTRODUCTION
  • 10.2 NORTH AMERICA
    NORTH AMERICA: RECESSION IMPACT
    US
    - US to dominate North American 3D bioprinting market during forecast period
    CANADA
    - Increased number of public-private partnerships for life science research to drive market
  • 10.3 EUROPE
    EUROPE: RECESSION IMPACT
    GERMANY
    - Rising healthcare expenditure and increasing demand for organ transplants to favor market growth
    UK
    - Rising prevalence of chronic diseases and increasing R&D activities to drive market
    FRANCE
    - Increasing availability of advanced medical technologies to support market growth
    ITALY
    - Increased research investment and funding to support market growth
    SPAIN
    - Favorable investment scenario and increase in number of research centers to aid market growth
    REST OF EUROPE
  • 10.4 ASIA PACIFIC
    CHINA
    - Increasing government focus on pharmaceutical R&D and growing demand for organ transplants to augment market growth
    JAPAN
    - Advancements in healthcare infrastructure to support market growth
    INDIA
    - Increasing developments in biopharmaceutical industry to propel market growth
    AUSTRALIA
    - Rising private and public funding for research activities to drive market
    SOUTH KOREA
    - Favorable government policies and high investments from private sector to fuel market growth
    REST OF ASIA PACIFIC
    ASIA PACIFIC: RECESSION IMPACT
  • 10.5 LATIN AMERICA
    LATIN AMERICA: RECESSION IMPACT
    BRAZIL
    - Brazil to hold largest share in Latin American market
    MEXICO
    - Increasing incidence of diabetes and growing geriatric population to aid market growth
    REST OF LATIN AMERICA
  • 10.6 MIDDLE EAST
    MIDDLE EAST: RECESSION IMPACT
    GCC COUNTRIES
    - Saudi Arabia
    - United Arab Emirates
    - Rest of GCC countries
    REST OF MIDDLE EAST
  • 10.7 AFRICA
    GROWING FOCUS ON FUNDING AND PARTNERSHIPS IN RESEARCH SECTOR TO AID MARKET GROWTH
    AFRICA: RECESSION IMPACT
COMPETITIVE LANDSCAPE
362
  • 11.1 INTRODUCTION
  • 11.2 KEY STRATEGIES/RIGHT TO WIN
  • 11.3 REVENUE ANALYSIS
  • 11.4 MARKET SHARE ANALYSIS
  • 11.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
    STARS
    EMERGING LEADERS
    PERVASIVE PLAYERS
    PARTICIPANTS
    COMPANY FOOTPRINT: KEY PLAYERS, 2023
    - Overall footprint
    - Component footprint
    - Regional footprint
    - Material footprint
    - Application footprint
  • 11.6 COMPANY EVALUATION MATRIX: START-UPS/SMES, 2023
    PROGRESSIVE COMPANIES
    RESPONSIVE COMPANIES
    DYNAMIC COMPANIES
    STARTING BLOCKS
    COMPETITIVE BENCHMARKING: START-UPS/SMES, 2023
  • 11.7 VALUATION AND FINANCIAL METRICS
  • 11.8 BRAND/PRODUCT COMPARISON
    BICO GROUP AB
    REGENHU
    ROKIT HEALTHCARE, INC.
  • 11.9 COMPETITIVE SCENARIO
    PRODUCT LAUNCHES
    DEALS
    EXPANSIONS
    OTHER DEVELOPMENTS
COMPANY PROFILES
380
  • 12.1 KEY PLAYERS
    BICO GROUP AB
    - Business overview
    - Products/Services/Solutions offered
    - Recent developments
    - MnM view
    3D SYSTEMS, INC.
    - Business overview
    - Products/Services/Solutions offered
    - Recent developments
    - MnM view
    MERCK KGAA
    - Business overview
    - Products/Services/Solutions offered
    - Recent developments
    - MnM view
    ORGANOVO HOLDINGS INC.
    - Business overview
    - Products/Services/Solutions offered
    - Recent developments
    - MnM view
    COLLPLANT BIOTECHNOLOGIES LTD.
    - Business overview
    - Products/Services/Solutions offered
    - Recent developments
    - MnM view
    REGENHU
    - Business overview
    - Products/Services/Solutions offered
    ASPECT BIOSYSTEMS LTD.
    - Business overview
    - Products/Services/Solutions offered
    - Recent developments
    ADVANCED SOLUTIONS LIFE SCIENCES, LLC
    - Business overview
    - Products/Services/Solutions offered
    - Recent developments
    CYFUSE BIOMEDICAL K.K.
    - Business overview
    - Products/Services/Solutions offered
    ROKIT HEALTHCARE, INC.
    - Business overview
    - Products/Services/Solutions offered
    HANGZHOU GENOFEI BIOTECHNOLOGY CO., LTD.
    - Business overview
    - Products/Services/Solutions offered
    FOLDINK
    - Business overview
    - Products/Services/Solutions offered
    BRINTER
    - Business overview
    - Products/Services/Solutions offered
    - Recent developments
    3D BIOPRINTING SOLUTIONS
    - Business overview
    - Products/Services/Solutions offered
  • 12.2 OTHER PLAYERS
    REGEMAT 3D, SL
    ΡΟΙΕTIS
    SUNP BIOTECH
    GESIM–GESELLSCHAFT FÜR SILIZIUM-MIKROSYSTEME MBH
    MEDPRIN
    VOXCELL BIOINNOVATION INC.
    PRODWAYS
    INVENTIA LIFE SCIENCE PTY LTD.
    UPNANO GMBH
    UPM
    TISSUELABS
APPENDIX
446
  • 13.1 DISCUSSION GUIDE
  • 13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
  • 13.3 CUSTOMIZATION OPTIONS
  • 13.4 RELATED REPORTS
  • 13.5 AUTHOR DETAILS
LIST OF TABLES
 
  • TABLE 1 IMPACT ANALYSIS OF SUPPLY-SIDE AND DEMAND-SIDE FACTORS
  • TABLE 2 3D BIOPRINTING MARKET: AVERAGE SELLING PRICE OF COMPONENTS, BY REGION, 2021–2023
  • TABLE 3 3D BIOPRINTING MARKET: ROLE IN SUPPLY CHAIN
  • TABLE 4 3D BIOPRINTER VENDORS: ROLE IN ECOSYSTEM
  • TABLE 5 BIOINK VENDORS: ROLE IN ECOSYSTEM
  • TABLE 6 END USERS: ROLE IN ECOSYSTEM
  • TABLE 7 REGULATORY BODIES: ROLE IN ECOSYSTEM
  • TABLE 8 NUMBER OF PATENTS APPLIED AND GRANTED, 2014–2024
  • TABLE 9 3D BIOPRINTING MARKET: TOP 12 PATENT OWNERS IN US, 2014–2024
  • TABLE 10 PATENTS IN 3D BIOPRINTING MARKET, 2023
  • TABLE 11 IMPORT VOLUME FOR INK-JET PRINTING MACHINES (HS CODE: 844351), 2019–2023 (TONS)
  • TABLE 12 EXPORT VOLUME FOR INK-JET PRINTING MACHINES (HS CODE: 844351), 2019–2023 (TONS)
  • TABLE 13 IMPORT VOLUME FOR PRINTERS, COPYING MACHINES, AND FACSIMILE MACHINES, WHETHER OR NOT COMBINED (HS CODE: 844339), 2019–2023 (USD)
  • TABLE 14 EXPORT VOLUME FOR PRINTERS, COPYING MACHINES, AND FACSIMILE MACHINES, WHETHER OR NOT COMBINED (HS CODE-844339), 2019–2023 (USD)
  • TABLE 15 3D BIOPRINTING MARKET: KEY CONFERENCES AND EVENTS
  • TABLE 16 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 17 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 18 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 19 REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 20 3D BIOPRINTING MARKET: PORTER’S FIVE FORCES ANALYSIS
  • TABLE 21 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE END USERS
  • TABLE 22 KEY BUYING CRITERIA FOR TOP THREE END USERS IN 3D BIOPRINTERS MARKET
  • TABLE 23 3D BIOPRINTING MARKET, BY COMPONENT, 2022–2029 (USD MILLION)
  • TABLE 24 3D BIOPRINTING MARKET FOR 3D BIOPRINTERS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 25 3D BIOPRINTING MARKET FOR 3D BIOPRINTERS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 26 NORTH AMERICA: 3D BIOPRINTING MARKET FOR 3D BIOPRINTERS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 27 EUROPE: 3D BIOPRINTING MARKET FOR 3D BIOPRINTERS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 28 ASIA PACIFIC: 3D BIOPRINTING MARKET FOR 3D BIOPRINTERS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 29 LATIN AMERICA: 3D BIOPRINTING MARKET FOR 3D BIOPRINTERS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 30 MIDDLE EAST: 3D BIOPRINTING MARKET FOR 3D BIOPRINTERS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 31 GCC COUNTRIES: 3D BIOPRINTING MARKET FOR 3D BIOPRINTERS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 32 MICRO EXTRUSION BIOPRINTERS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 33 NORTH AMERICA: MICRO EXTRUSION BIOPRINTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 34 EUROPE: MICRO EXTRUSION BIOPRINTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 35 ASIA PACIFIC: MICRO EXTRUSION BIOPRINTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 36 LATIN AMERICA: MICRO EXTRUSION BIOPRINTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 37 MIDDLE EAST: MICRO EXTRUSION BIOPRINTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 38 GCC COUNTRIES: MICRO EXTRUSION BIOPRINTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 39 INKJET 3D BIOPRINTERS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 40 NORTH AMERICA: INKJET 3D BIOPRINTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 41 EUROPE: INKJET 3D BIOPRINTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 42 ASIA PACIFIC: INKJET 3D BIOPRINTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 43 LATIN AMERICA: INKJET 3D BIOPRINTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 44 MIDDLE EAST: INKJET 3D BIOPRINTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 45 GCC COUNTRIES: INKJET 3D BIOPRINTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 46 LASER-ASSISTED BIOPRINTERS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 47 NORTH AMERICA: LASER-ASSISTED BIOPRINTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 48 EUROPE: LASER-ASSISTED BIOPRINTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 49 ASIA PACIFIC: LASER-ASSISTED BIOPRINTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 50 LATIN AMERICA: LASER-ASSISTED BIOPRINTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 51 MIDDLE EAST: LASER-ASSISTED BIOPRINTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 52 GCC COUNTRIES: LASER-ASSISTED BIOPRINTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 53 STEREOLITHOGRAPHY-BASED BIOPRINTERS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 54 NORTH AMERICA: STEREOLITHOGRAPHY-BASED BIOPRINTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 55 EUROPE: STEREOLITHOGRAPHY-BASED BIOPRINTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 56 ASIA PACIFIC: STEREOLITHOGRAPHY-BASED BIOPRINTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 57 LATIN AMERICA: STEREOLITHOGRAPHY-BASED BIOPRINTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 58 MIDDLE EAST: STEREOLITHOGRAPHY-BASED BIOPRINTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 59 GCC COUNTRIES: STEREOLITHOGRAPHY-BASED BIOPRINTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 60 MAGNETIC 3D BIOPRINTERS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 61 NORTH AMERICA: MAGNETIC 3D BIOPRINTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 62 EUROPE: MAGNETIC 3D BIOPRINTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 63 ASIA PACIFIC: MAGNETIC 3D BIOPRINTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 64 LATIN AMERICA: MAGNETIC 3D BIOPRINTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 65 MIDDLE EAST: MAGNETIC 3D BIOPRINTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 66 GCC COUNTRIES: MAGNETIC 3D BIOPRINTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 67 OTHER 3D BIOPRINTERS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 68 NORTH AMERICA: OTHER 3D BIOPRINTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 69 EUROPE: OTHER 3D BIOPRINTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 70 ASIA PACIFIC: OTHER 3D BIOPRINTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 71 LATIN AMERICA: OTHER 3D BIOPRINTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 72 MIDDLE EAST: OTHER 3D BIOPRINTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 73 GCC COUNTRIES: OTHER 3D BIOPRINTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 74 3D BIOPRINTERS MARKET FOR BIOINKS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 75 3D BIOPRINTING MARKET FOR BIOINKS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 76 NORTH AMERICA: 3D BIOPRINTING MARKET FOR BIOINKS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 77 EUROPE: 3D BIOPRINTING MARKET FOR BIOINKS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 78 ASIA PACIFIC: 3D BIOPRINTING MARKET FOR BIOINKS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 79 LATIN AMERICA: 3D BIOPRINTING MARKET FOR BIOINKS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 80 MIDDLE EAST: 3D BIOPRINTING MARKET FOR BIOINKS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 81 GCC COUNTRIES: 3D BIOPRINTING MARKET FOR BIOINKS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 82 NATURAL BIOINKS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 83 NORTH AMERICA: NATURAL BIOINKS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 84 EUROPE: NATURAL BIOINKS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 85 ASIA PACIFIC: NATURAL BIOINKS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 86 LATIN AMERICA: NATURAL BIOINKS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 87 MIDDLE EAST: NATURAL BIOINKS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 88 GCC COUNTRIES: NATURAL BIOINKS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 89 HYBRID BIOINKS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 90 NORTH AMERICA: HYBRID BIOINKS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 91 EUROPE: HYBRID BIOINKS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 92 ASIA PACIFIC: HYBRID BIOINKS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 93 LATIN AMERICA: HYBRID BIOINKS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 94 MIDDLE EAST: HYBRID BIOINKS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 95 GCC COUNTRIES: HYBRID BIOINKS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 96 SYNTHETIC BIOINKS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 97 NORTH AMERICA: SYNTHETIC BIOINKS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 98 EUROPE: SYNTHETIC BIOINKS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 99 ASIA PACIFIC: SYNTHETIC BIOINKS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 100 LATIN AMERICA: SYNTHETIC BIOINKS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 101 MIDDLE EAST: SYNTHETIC BIOINKS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 102 GCC COUNTRIES: SYNTHETIC BIOINKS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 103 3D BIOPRINTING MARKET FOR SOFTWARE, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 104 NORTH AMERICA: 3D BIOPRINTING MARKET FOR SOFTWARE, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 105 EUROPE: 3D BIOPRINTING MARKET FOR SOFTWARE, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 106 ASIA PACIFIC: 3D BIOPRINTING MARKET FOR SOFTWARE, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 107 LATIN AMERICA: 3D BIOPRINTING MARKET FOR SOFTWARE, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 108 MIDDLE EAST: 3D BIOPRINTING MARKET FOR SOFTWARE, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 109 GCC COUNTRIES: 3D BIOPRINTING MARKET FOR SOFTWARE, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 110 3D BIOPRINTING MARKET FOR CONSUMABLES, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 111 NORTH AMERICA: 3D BIOPRINTING MARKET FOR CONSUMABLES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 112 EUROPE: 3D BIOPRINTING MARKET FOR CONSUMABLES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 113 ASIA PACIFIC: 3D BIOPRINTING MARKET FOR CONSUMABLES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 114 LATIN AMERICA: 3D BIOPRINTING MARKET FOR CONSUMABLES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 115 MIDDLE EAST: 3D BIOPRINTING MARKET FOR CONSUMABLES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 116 GCC COUNTRIES: 3D BIOPRINTING MARKET FOR CONSUMABLES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 117 3D BIOPRINTING MARKET, BY MATERIAL, 2022–2029 (USD MILLION)
  • TABLE 118 3D BIOPRINTING MARKET FOR LIVING CELLS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 119 NORTH AMERICA: 3D BIOPRINTING MARKET FOR LIVING CELLS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 120 EUROPE: 3D BIOPRINTING MARKET FOR LIVING CELLS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 121 ASIA PACIFIC: 3D BIOPRINTING MARKET FOR LIVING CELLS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 122 LATIN AMERICA: 3D BIOPRINTING MARKET FOR LIVING CELLS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 123 MIDDLE EAST: 3D BIOPRINTING MARKET FOR LIVING CELLS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 124 GCC COUNTRIES: 3D BIOPRINTING MARKET FOR LIVING CELLS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 125 3D BIOPRINTING MARKET FOR HYDROGELS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 126 NORTH AMERICA: 3D BIOPRINTING MARKET FOR HYDROGELS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 127 EUROPE: 3D BIOPRINTING MARKET FOR HYDROGELS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 128 ASIA PACIFIC: 3D BIOPRINTING MARKET FOR HYDROGELS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 129 LATIN AMERICA: 3D BIOPRINTING MARKET FOR HYDROGELS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 130 MIDDLE EAST: 3D BIOPRINTING MARKET FOR HYDROGELS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 131 GCC COUNTRIES: 3D BIOPRINTING MARKET FOR HYDROGELS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 132 3D BIOPRINTING MARKET FOR EXTRACELLULAR MATRICES, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 133 NORTH AMERICA: 3D BIOPRINTING MARKET FOR EXTRACELLULAR MATRICES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 134 EUROPE: 3D BIOPRINTING MARKET FOR EXTRACELLULAR MATRICES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 135 ASIA PACIFIC: 3D BIOPRINTING MARKET FOR EXTRACELLULAR MATRICES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 136 LATIN AMERICA: 3D BIOPRINTING MARKET FOR EXTRACELLULAR MATRICES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 137 MIDDLE EAST: 3D BIOPRINTING MARKET FOR EXTRACELLULAR MATRICES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 138 GCC COUNTRIES: 3D BIOPRINTING MARKET FOR EXTRACELLULAR MATRICES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 139 3D BIOPRINTING MARKET FOR OTHER MATERIALS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 140 NORTH AMERICA: 3D BIOPRINTING MARKET FOR OTHER MATERIALS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 141 EUROPE: 3D BIOPRINTING MARKET FOR OTHER MATERIALS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 142 ASIA PACIFIC: 3D BIOPRINTING MARKET FOR OTHER MATERIALS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 143 LATIN AMERICA: 3D BIOPRINTING MARKET FOR OTHER MATERIALS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 144 MIDDLE EAST: 3D BIOPRINTING MARKET FOR OTHER MATERIALS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 145 GCC COUNTRIES: 3D BIOPRINTING MARKET FOR OTHER MATERIALS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 146 3D BIOPRINTING MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 147 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 148 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 149 NORTH AMERICA: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 150 EUROPE: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 151 ASIA PACIFIC: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 152 LATIN AMERICA: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 153 MIDDLE EAST: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 154 GCC COUNTRIES: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 155 DRUG RESEARCH MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 156 NORTH AMERICA: DRUG RESEARCH MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 157 EUROPE: DRUG RESEARCH MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 158 ASIA PACIFIC: DRUG RESEARCH MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 159 LATIN AMERICA: DRUG RESEARCH MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 160 MIDDLE EAST: DRUG RESEARCH MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 161 GCC COUNTRIES: DRUG RESEARCH MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 162 REGENERATIVE MEDICINE MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 163 NORTH AMERICA: REGENERATIVE MEDICINE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 164 EUROPE: REGENERATIVE MEDICINE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 165 ASIA PACIFIC: REGENERATIVE MEDICINE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 166 LATIN AMERICA: REGENERATIVE MEDICINE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 167 MIDDLE EAST: REGENERATIVE MEDICINE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 168 GCC COUNTRIES: REGENERATIVE MEDICINE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 169 3D CELL CULTURE MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 170 NORTH AMERICA: 3D CELL CULTURE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 171 EUROPE: 3D CELL CULTURE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 172 ASIA PACIFIC: 3D CELL CULTURE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 173 LATIN AMERICA: 3D CELL CULTURE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 174 MIDDLE EAST: 3D CELL CULTURE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 175 GCC COUNTRIES: 3D CELL CULTURE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 176 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 177 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 178 NORTH AMERICA: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 179 EUROPE: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 180 ASIA PACIFIC: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 181 LATIN AMERICA: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 182 MIDDLE EAST: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 183 GCC COUNTRIES: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 184 SKIN MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 185 NORTH AMERICA: SKIN MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 186 EUROPE: SKIN MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 187 ASIA PACIFIC: SKIN MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 188 LATIN AMERICA: SKIN MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 189 MIDDLE EAST: SKIN MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 190 GCC COUNTRIES: SKIN MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 191 BONE & CARTILAGE MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 192 NORTH AMERICA: BONE & CARTILAGE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 193 EUROPE: BONE & CARTILAGE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 194 ASIA PACIFIC: BONE & CARTILAGE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 195 LATIN AMERICA: BONE & CARTILAGE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 196 MIDDLE EAST: BONE & CARTILAGE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 197 GCC COUNTRIES: BONE & CARTILAGE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 198 BLOOD VESSELS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 199 NORTH AMERICA: BLOOD VESSELS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 200 EUROPE: BLOOD VESSELS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 201 ASIA PACIFIC: BLOOD VESSELS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 202 LATIN AMERICA: BLOOD VESSELS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 203 MIDDLE EAST: BLOOD VESSELS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 204 GCC COUNTRIES: BLOOD VESSELS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 205 OTHER CLINICAL APPLICATIONS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 206 NORTH AMERICA: OTHER CLINICAL APPLICATIONS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 207 EUROPE: OTHER CLINICAL APPLICATIONS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 208 ASIA PACIFIC: OTHER CLINICAL APPLICATIONS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 209 LATIN AMERICA: OTHER CLINICAL APPLICATIONS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 210 MIDDLE EAST: OTHER CLINICAL APPLICATIONS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 211 GCC COUNTRIES: OTHER CLINICAL APPLICATIONS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 212 3D BIOPRINTING MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 213 3D BIOPRINTING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 214 NORTH AMERICA: 3D BIOPRINTING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 215 EUROPE: 3D BIOPRINTING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 216 ASIA PACIFIC: 3D BIOPRINTING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 217 LATIN AMERICA: 3D BIOPRINTING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 218 MIDDLE EAST: 3D BIOPRINTING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 219 GCC COUNTRIES: 3D BIOPRINTING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 220 3D BIOPRINTING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 221 NORTH AMERICA: 3D BIOPRINTING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 222 EUROPE: 3D BIOPRINTING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 223 ASIA PACIFIC: 3D BIOPRINTING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 224 LATIN AMERICA: 3D BIOPRINTING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 225 MIDDLE EAST: 3D BIOPRINTING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 226 GCC COUNTRIES: 3D BIOPRINTING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 227 3D BIOPRINTING MARKET FOR HOSPITALS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 228 NORTH AMERICA: 3D BIOPRINTING MARKET FOR HOSPITALS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 229 EUROPE: 3D BIOPRINTING MARKET FOR HOSPITALS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 230 ASIA PACIFIC: 3D BIOPRINTING MARKET FOR HOSPITALS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 231 LATIN AMERICA: 3D BIOPRINTING MARKET FOR HOSPITALS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 232 MIDDLE EAST: 3D BIOPRINTING MARKET FOR HOSPITALS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 233 GCC COUNTRIES: 3D BIOPRINTING MARKET FOR HOSPITALS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 234 3D BIOPRINTING MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 235 NORTH AMERICA: 3D BIOPRINTING MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 236 NORTH AMERICA: 3D BIOPRINTING MARKET, BY COMPONENT, 2022–2029 (USD MILLION)
  • TABLE 237 NORTH AMERICA: 3D BIOPRINTING MARKET FOR 3D BIOPRINTERS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 238 NORTH AMERICA: 3D BIOPRINTING MARKET FOR BIOINKS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 239 NORTH AMERICA: 3D BIOPRINTING MARKET, BY MATERIAL, 2022–2029 (USD MILLION)
  • TABLE 240 NORTH AMERICA: 3D BIOPRINTING MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 241 NORTH AMERICA: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 242 NORTH AMERICA: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 243 NORTH AMERICA: 3D BIOPRINTING MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 244 US: 3D BIOPRINTING MARKET, BY COMPONENT, 2022–2029 (USD MILLION)
  • TABLE 245 US: 3D BIOPRINTING MARKET FOR 3D BIOPRINTERS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 246 US: 3D BIOPRINTING MARKET FOR BIOINKS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 247 US: 3D BIOPRINTING MARKET, BY MATERIAL, 2022–2029 (USD MILLION)
  • TABLE 248 US: 3D BIOPRINTING MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 249 US: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 250 US: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 251 US: 3D BIOPRINTING MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 252 CANADA: 3D BIOPRINTING MARKET, BY COMPONENT, 2022–2029 (USD MILLION)
  • TABLE 253 CANADA: 3D BIOPRINTING MARKET FOR 3D BIOPRINTERS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 254 CANADA: 3D BIOPRINTING MARKET FOR BIOINKS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 255 CANADA: 3D BIOPRINTING MARKET, BY MATERIAL, 2022–2029 (USD MILLION)
  • TABLE 256 CANADA: 3D BIOPRINTING MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 257 CANADA: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 258 CANADA: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 259 CANADA: 3D BIOPRINTING MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 260 EUROPE: 3D BIOPRINTING MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 261 EUROPE: 3D BIOPRINTING MARKET, BY COMPONENT, 2022–2029 (USD MILLION)
  • TABLE 262 EUROPE: 3D BIOPRINTING MARKET FOR 3D BIOPRINTERS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 263 EUROPE: 3D BIOPRINTING MARKET FOR BIOINKS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 264 EUROPE: 3D BIOPRINTING MARKET, BY MATERIAL, 2022–2029 (USD MILLION)
  • TABLE 265 EUROPE: 3D BIOPRINTING MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 266 EUROPE: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 267 EUROPE: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 268 EUROPE: 3D BIOPRINTING MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 269 GERMANY: 3D BIOPRINTING MARKET, BY COMPONENT, 2022–2029 (USD MILLION)
  • TABLE 270 GERMANY: 3D BIOPRINTING MARKET FOR 3D BIOPRINTERS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 271 GERMANY: 3D BIOPRINTING MARKET FOR BIOINKS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 272 GERMANY: 3D BIOPRINTING MARKET, BY MATERIAL, 2022–2029 (USD MILLION)
  • TABLE 273 GERMANY: 3D BIOPRINTING MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 274 GERMANY: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 275 GERMANY: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 276 GERMANY: 3D BIOPRINTING MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 277 UK: 3D BIOPRINTING MARKET, BY COMPONENT, 2022–2029 (USD MILLION)
  • TABLE 278 UK: 3D BIOPRINTING MARKET FOR 3D BIOPRINTERS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 279 UK: 3D BIOPRINTING MARKET FOR BIOINKS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 280 UK: 3D BIOPRINTING MARKET, BY MATERIAL, 2022–2029 (USD MILLION)
  • TABLE 281 UK: 3D BIOPRINTING MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 282 UK: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 283 UK: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 284 UK: 3D BIOPRINTING MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 285 FRANCE: 3D BIOPRINTING MARKET, BY COMPONENT, 2022–2029 (USD MILLION)
  • TABLE 286 FRANCE: 3D BIOPRINTING MARKET FOR 3D BIOPRINTERS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 287 FRANCE: 3D BIOPRINTING MARKET FOR BIOINKS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 288 FRANCE: 3D BIOPRINTING MARKET, BY MATERIAL, 2022–2029 (USD MILLION)
  • TABLE 289 FRANCE: 3D BIOPRINTING MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 290 FRANCE: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 291 FRANCE: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 292 FRANCE: 3D BIOPRINTING MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 293 ITALY: 3D BIOPRINTING MARKET, BY COMPONENT, 2022–2029 (USD MILLION)
  • TABLE 294 ITALY: 3D BIOPRINTING MARKET FOR 3D BIOPRINTERS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 295 ITALY: 3D BIOPRINTING MARKET FOR BIOINKS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 296 ITALY: 3D BIOPRINTING MARKET, BY MATERIAL, 2022–2029 (USD MILLION)
  • TABLE 297 ITALY: 3D BIOPRINTING MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 298 ITALY: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 299 ITALY: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 300 ITALY: 3D BIOPRINTING MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 301 SPAIN: 3D BIOPRINTING MARKET, BY COMPONENT, 2022–2029 (USD MILLION)
  • TABLE 302 SPAIN: 3D BIOPRINTING MARKET FOR 3D BIOPRINTERS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 303 SPAIN: 3D BIOPRINTING MARKET FOR BIOINKS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 304 SPAIN: 3D BIOPRINTING MARKET, BY MATERIAL, 2022–2029 (USD MILLION)
  • TABLE 305 SPAIN: 3D BIOPRINTING MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 306 SPAIN: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 307 SPAIN: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 308 SPAIN: 3D BIOPRINTING MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 309 REST OF EUROPE: 3D BIOPRINTING MARKET, BY COMPONENT, 2022–2029 (USD MILLION)
  • TABLE 310 REST OF EUROPE: 3D BIOPRINTING MARKET FOR 3D BIOPRINTERS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 311 REST OF EUROPE: 3D BIOPRINTING MARKET FOR BIOINKS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 312 REST OF EUROPE: 3D BIOPRINTING MARKET, BY MATERIAL, 2022–2029 (USD MILLION)
  • TABLE 313 REST OF EUROPE: 3D BIOPRINTING MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 314 REST OF EUROPE: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 315 REST OF EUROPE: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 316 REST OF EUROPE: 3D BIOPRINTING MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 317 ASIA PACIFIC: 3D BIOPRINTING MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 318 ASIA PACIFIC: 3D BIOPRINTING MARKET, BY COMPONENT, 2022–2029 (USD MILLION)
  • TABLE 319 ASIA PACIFIC: 3D BIOPRINTING MARKET FOR 3D BIOPRINTERS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 320 ASIA PACIFIC: 3D BIOPRINTING MARKET FOR BIOINKS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 321 ASIA PACIFIC: 3D BIOPRINTING MARKET, BY MATERIAL, 2022–2029 (USD MILLION)
  • TABLE 322 ASIA PACIFIC: 3D BIOPRINTING MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 323 ASIA PACIFIC: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 324 ASIA PACIFIC: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 325 ASIA PACIFIC: 3D BIOPRINTING MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 326 CHINA: 3D BIOPRINTING MARKET, BY COMPONENT, 2022–2029 (USD MILLION)
  • TABLE 327 CHINA: 3D BIOPRINTING MARKET FOR 3D BIOPRINTERS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 328 CHINA: 3D BIOPRINTING MARKET FOR BIOINKS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 329 CHINA: 3D BIOPRINTING MARKET, BY MATERIAL, 2022–2029 (USD MILLION)
  • TABLE 330 CHINA: 3D BIOPRINTING MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 331 CHINA: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 332 CHINA: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 333 CHINA: 3D BIOPRINTING MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 334 JAPAN: 3D BIOPRINTING MARKET, BY COMPONENT, 2022–2029 (USD MILLION)
  • TABLE 335 JAPAN: 3D BIOPRINTING MARKET FOR 3D BIOPRINTERS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 336 JAPAN: 3D BIOPRINTING MARKET FOR BIOINKS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 337 JAPAN: 3D BIOPRINTING MARKET, BY MATERIAL, 2022–2029 (USD MILLION)
  • TABLE 338 JAPAN: 3D BIOPRINTING MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 339 JAPAN: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 340 JAPAN: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 341 JAPAN: 3D BIOPRINTING MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 342 INDIA: 3D BIOPRINTING MARKET, BY COMPONENT, 2022–2029 (USD MILLION)
  • TABLE 343 INDIA: 3D BIOPRINTING MARKET FOR 3D BIOPRINTERS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 344 INDIA: 3D BIOPRINTING MARKET FOR BIOINKS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 345 INDIA: 3D BIOPRINTING MARKET, BY MATERIAL, 2022–2029 (USD MILLION)
  • TABLE 346 INDIA: 3D BIOPRINTING MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 347 INDIA: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 348 INDIA: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 349 INDIA: 3D BIOPRINTING MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 350 AUSTRALIA: 3D BIOPRINTING MARKET, BY COMPONENT, 2022–2029 (USD MILLION)
  • TABLE 351 AUSTRALIA: 3D BIOPRINTING MARKET FOR 3D BIOPRINTERS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 352 AUSTRALIA: 3D BIOPRINTING MARKET FOR BIOINKS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 353 AUSTRALIA: 3D BIOPRINTING MARKET, BY MATERIAL, 2022–2029 (USD MILLION)
  • TABLE 354 AUSTRALIA: 3D BIOPRINTING MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 355 AUSTRALIA: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 356 AUSTRALIA: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 357 AUSTRALIA: 3D BIOPRINTING MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 358 SOUTH KOREA: 3D BIOPRINTING MARKET, BY COMPONENT, 2022–2029 (USD MILLION)
  • TABLE 359 SOUTH KOREA: 3D BIOPRINTING MARKET FOR 3D BIOPRINTERS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 360 SOUTH KOREA: 3D BIOPRINTING MARKET FOR BIOINKS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 361 SOUTH KOREA: 3D BIOPRINTING MARKET, BY MATERIAL, 2022–2029 (USD MILLION)
  • TABLE 362 SOUTH KOREA: 3D BIOPRINTING MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 363 SOUTH KOREA: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 364 SOUTH KOREA: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 365 SOUTH KOREA: 3D BIOPRINTING MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 366 REST OF ASIA PACIFIC: 3D BIOPRINTING MARKET, BY COMPONENT, 2022–2029 (USD MILLION)
  • TABLE 367 REST OF ASIA PACIFIC: 3D BIOPRINTING MARKET FOR 3D BIOPRINTERS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 368 REST OF ASIA PACIFIC: 3D BIOPRINTING MARKET FOR BIOINKS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 369 REST OF ASIA PACIFIC: 3D BIOPRINTING MARKET, BY MATERIAL, 2022–2029 (USD MILLION)
  • TABLE 370 REST OF ASIA PACIFIC: 3D BIOPRINTING MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 371 REST OF ASIA PACIFIC: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 372 REST OF ASIA PACIFIC: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 373 REST OF ASIA PACIFIC: 3D BIOPRINTING MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 374 LATIN AMERICA: 3D BIOPRINTING MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 375 LATIN AMERICA: 3D BIOPRINTING MARKET, BY COMPONENT, 2022–2029 (USD MILLION)
  • TABLE 376 LATIN AMERICA: 3D BIOPRINTING MARKET FOR 3D BIOPRINTERS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 377 LATIN AMERICA: 3D BIOPRINTING MARKET FOR BIOINKS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 378 LATIN AMERICA: 3D BIOPRINTING MARKET, BY MATERIAL, 2022–2029 (USD MILLION)
  • TABLE 379 LATIN AMERICA: 3D BIOPRINTING MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 380 LATIN AMERICA: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 381 LATIN AMERICA: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 382 LATIN AMERICA: 3D BIOPRINTING MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 383 BRAZIL: 3D BIOPRINTING MARKET, BY COMPONENT, 2022–2029 (USD MILLION)
  • TABLE 384 BRAZIL: 3D BIOPRINTING MARKET FOR 3D BIOPRINTERS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 385 BRAZIL: 3D BIOPRINTING MARKET FOR BIOINKS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 386 BRAZIL: 3D BIOPRINTING MARKET, BY MATERIAL, 2022–2029 (USD MILLION)
  • TABLE 387 BRAZIL: 3D BIOPRINTING MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 388 BRAZIL: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 389 BRAZIL: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 390 BRAZIL: 3D BIOPRINTING MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 391 MEXICO: 3D BIOPRINTING MARKET, BY COMPONENT, 2022–2029 (USD MILLION)
  • TABLE 392 MEXICO: 3D BIOPRINTING MARKET FOR 3D BIOPRINTERS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 393 MEXICO: 3D BIOPRINTING MARKET FOR BIOINKS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 394 MEXICO: 3D BIOPRINTING MARKET, BY MATERIAL, 2022–2029 (USD MILLION)
  • TABLE 395 MEXICO: 3D BIOPRINTING MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 396 MEXICO: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 397 MEXICO: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 398 MEXICO: 3D BIOPRINTING MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 399 REST OF LATIN AMERICA: 3D BIOPRINTING MARKET, BY COMPONENT, 2022–2029 (USD MILLION)
  • TABLE 400 REST OF LATIN AMERICA: 3D BIOPRINTING MARKET FOR 3D BIOPRINTERS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 401 REST OF LATIN AMERICA: 3D BIOPRINTING MARKET FOR BIOINKS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 402 REST OF LATIN AMERICA: 3D BIOPRINTING MARKET, BY MATERIAL, 2022–2029 (USD MILLION)
  • TABLE 403 REST OF LATIN AMERICA: 3D BIOPRINTING MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 404 REST OF LATIN AMERICA: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 405 REST OF LATIN AMERICA: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 406 REST OF LATIN AMERICA: 3D BIOPRINTING MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 407 MIDDLE EAST: 3D BIOPRINTING MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 408 MIDDLE EAST: 3D BIOPRINTING MARKET, BY COMPONENT, 2022–2029 (USD MILLION)
  • TABLE 409 MIDDLE EAST: 3D BIOPRINTING MARKET FOR 3D BIOPRINTERS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 410 MIDDLE EAST: 3D BIOPRINTING MARKET FOR BIOINKS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 411 MIDDLE EAST: 3D BIOPRINTING MARKET, BY MATERIAL, 2022–2029 (USD MILLION)
  • TABLE 412 MIDDLE EAST: 3D BIOPRINTING MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 413 MIDDLE EAST: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 414 MIDDLE EAST: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 415 MIDDLE EAST: 3D BIOPRINTING MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 416 GCC COUNTRIES: 3D BIOPRINTING MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 417 GCC COUNTRIES: 3D BIOPRINTING MARKET, BY COMPONENT, 2022–2029 (USD MILLION)
  • TABLE 418 GCC COUNTRIES: 3D BIOPRINTING MARKET FOR 3D BIOPRINTERS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 419 GCC COUNTRIES: 3D BIOPRINTING MARKET FOR BIOINKS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 420 GCC COUNTRIES: 3D BIOPRINTING MARKET, BY MATERIAL, 2022–2029 (USD MILLION)
  • TABLE 421 GCC COUNTRIES: 3D BIOPRINTING MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 422 GCC COUNTRIES: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 423 GCC COUNTRIES: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 424 GCC COUNTRIES: 3D BIOPRINTING MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 425 SAUDI ARABIA: 3D BIOPRINTING MARKET, BY COMPONENT, 2022–2029 (USD MILLION)
  • TABLE 426 SAUDI ARABIA: 3D BIOPRINTING MARKET FOR 3D BIOPRINTERS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 427 SAUDI ARABIA: 3D BIOPRINTING MARKET FOR BIOINKS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 428 SAUDI ARABIA: 3D BIOPRINTING MARKET, BY MATERIAL, 2022–2029 (USD MILLION)
  • TABLE 429 SAUDI ARABIA: 3D BIOPRINTING MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 430 SAUDI ARABIA: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 431 SAUDI ARABIA: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 432 SAUDI ARABIA: 3D BIOPRINTING MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 433 UNITED ARAB EMIRATES: 3D BIOPRINTING MARKET, BY COMPONENT, 2022–2029 (USD MILLION)
  • TABLE 434 UNITED ARAB EMIRATES: 3D BIOPRINTING MARKET FOR 3D BIOPRINTERS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 435 UNITED ARAB EMIRATES: 3D BIOPRINTING MARKET FOR BIOINKS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 436 UNITED ARAB EMIRATES: 3D BIOPRINTING MARKET, BY MATERIAL, 2022–2029 (USD MILLION)
  • TABLE 437 UNITED ARAB EMIRATES: 3D BIOPRINTING MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 438 UNITED ARAB EMIRATES: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 439 UNITED ARAB EMIRATES: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 440 UNITED ARAB EMIRATES: 3D BIOPRINTING MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 441 REST OF GCC COUNTRIES: 3D BIOPRINTING MARKET, BY COMPONENT, 2022–2029 (USD MILLION)
  • TABLE 442 REST OF GCC COUNTRIES: 3D BIOPRINTING MARKET FOR 3D BIOPRINTERS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 443 REST OF GCC COUNTRIES: 3D BIOPRINTING MARKET FOR BIOINKS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 444 REST OF GCC COUNTRIES: 3D BIOPRINTING MARKET, BY MATERIAL, 2022–2029 (USD MILLION)
  • TABLE 445 REST OF GCC COUNTRIES: 3D BIOPRINTING MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 446 REST OF GCC COUNTRIES: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 447 REST OF GCC COUNTRIES: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 448 REST OF GCC COUNTRIES: 3D BIOPRINTING MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 449 REST OF MIDDLE EAST: 3D BIOPRINTING MARKET, BY COMPONENT, 2022–2029 (USD MILLION)
  • TABLE 450 REST OF MIDDLE EAST: 3D BIOPRINTING MARKET FOR 3D BIOPRINTERS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 451 REST OF MIDDLE EAST: 3D BIOPRINTING MARKET FOR BIOINKS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 452 REST OF MIDDLE EAST: 3D BIOPRINTING MARKET, BY MATERIAL, 2022–2029 (USD MILLION)
  • TABLE 453 REST OF MIDDLE EAST: 3D BIOPRINTING MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 454 REST OF MIDDLE EAST: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 455 REST OF MIDDLE EAST: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 456 REST OF MIDDLE EAST: 3D BIOPRINTING MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 457 AFRICA: 3D BIOPRINTING MARKET, BY COMPONENT, 2022–2029 (USD MILLION)
  • TABLE 458 AFRICA: 3D BIOPRINTING MARKET FOR 3D BIOPRINTERS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 459 AFRICA: 3D BIOPRINTING MARKET FOR BIOINKS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 460 AFRICA: 3D BIOPRINTING MARKET, BY MATERIAL, 2022–2029 (USD MILLION)
  • TABLE 461 AFRICA: 3D BIOPRINTING MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 462 AFRICA: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 463 AFRICA: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 464 AFRICA: 3D BIOPRINTING MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 465 3D BIOPRINTING MARKET: DEGREE OF COMPETITION
  • TABLE 466 3D BIOPRINTING MARKET: COMPONENT FOOTPRINT
  • TABLE 467 3D BIOPRINTING MARKET: REGIONAL FOOTPRINT
  • TABLE 468 3D BIOPRINTING MARKET: MATERIAL FOOTPRINT
  • TABLE 469 3D BIOPRINTING MARKET: APPLICATION FOOTPRINT
  • TABLE 470 3D BIOPRINTING MARKET: DETAILED LIST OF KEY START-UPS/SMES
  • TABLE 471 3D BIOPRINTING MARKET: COMPETITIVE BENCHMARKING OF KEY START-UPS/SMES
  • TABLE 472 3D BIOPRINTING MARKET: PRODUCT LAUNCHES, JANUARY 2021–MARCH 2024
  • TABLE 473 3D BIOPRINTING MARKET: DEALS, JANUARY 2021–MARCH 2024
  • TABLE 474 3D BIOPRINTING MARKET: EXPANSIONS, JANUARY 2021–MARCH 2024
  • TABLE 475 3D BIOPRINTING MARKET: OTHER DEVELOPMENTS, JANUARY 2021–MARCH 2024
  • TABLE 476 BICO GROUP AB: COMPANY OVERVIEW
  • TABLE 477 BICO GROUP AB: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 478 BICO GROUP AB: PRODUCT LAUNCHES
  • TABLE 479 BICO GROUP AB: DEALS
  • TABLE 480 BICO GROUP AB: EXPANSIONS
  • TABLE 481 BICO GROUP AB: OTHER DEVELOPMENTS
  • TABLE 482 3D SYSTEMS, INC.: COMPANY OVERVIEW
  • TABLE 483 3D SYSTEMS, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 484 3D SYSTEMS, INC.: DEALS
  • TABLE 485 3D SYSTEMS, INC.: EXPANSIONS
  • TABLE 486 MERCK KGAA: COMPANY OVERVIEW
  • TABLE 487 MERCK KGAA: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 488 MERCK KGAA: EXPANSIONS
  • TABLE 489 ORGANOVO HOLDINGS INC.: COMPANY OVERVIEW
  • TABLE 490 ORGANOVO HOLDINGS INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 491 ORGANOVO HOLDINGS INC.: DEALS
  • TABLE 492 COLLPLANT BIOTECHNOLOGIES LTD.: COMPANY OVERVIEW
  • TABLE 493 COLLPLANT BIOTECHNOLOGIES LTD.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 494 COLLPLANT BIOTECHNOLOGIES LTD.: PIPELINE PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 495 COLLPLANT BIOTECHNOLOGIES LTD.: PRODUCT LAUNCHES
  • TABLE 496 COLLPLANT BIOTECHNOLOGIES LTD.: DEALS
  • TABLE 497 REGENHU: COMPANY OVERVIEW
  • TABLE 498 REGENHU: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 499 ASPECT BIOSYSTEMS LTD.: COMPANY OVERVIEW
  • TABLE 500 ASPECT BIOSYSTEMS LTD.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 501 ASPECT BIOSYSTEMS LTD.: DEALS
  • TABLE 502 ADVANCED SOLUTIONS LIFE SCIENCES, LLC: COMPANY OVERVIEW
  • TABLE 503 ADVANCED SOLUTIONS LIFE SCIENCES, LLC: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 504 ADVANCED SOLUTIONS LIFE SCIENCES, LLC: DEALS
  • TABLE 505 ADVANCED SOLUTIONS LIFE SCIENCES, LLC: OTHER DEVELOPMENTS
  • TABLE 506 CYFUSE BIOMEDICAL K.K.: COMPANY OVERVIEW
  • TABLE 507 CYFUSE BIOMEDICAL K.K.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 508 ROKIT HEALTHCARE, INC.: COMPANY OVERVIEW
  • TABLE 509 ROKIT HEALTHCARE, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 510 HANGZHOU GENOFEI BIOTECHNOLOGY CO., LTD.: COMPANY OVERVIEW
  • TABLE 511 HANGZHOU GENOFEI BIOTECHNOLOGY CO., LTD.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 512 FOLDINK: COMPANY OVERVIEW
  • TABLE 513 FOLDINK: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 514 BRINTER: COMPANY OVERVIEW
  • TABLE 515 BRINTER: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 516 BRINTER: DEALS
  • TABLE 517 BRINTER: EXPANSIONS
  • TABLE 518 3D BIOPRINTING SOLUTIONS: COMPANY OVERVIEW
  • TABLE 519 3D BIOPRINTING SOLUTIONS: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 520 REGEMAT 3D, SL: COMPANY OVERVIEW
  • TABLE 521 POIETIS: COMPANY OVERVIEW
  • TABLE 522 SUNP BIOTECH: COMPANY OVERVIEW
  • TABLE 523 GESIM–GESELLSCHAFT FÜR SILIZIUM-MIKROSYSTEME MBH: COMPANY OVERVIEW
  • TABLE 524 MEDPRIN: COMPANY OVERVIEW
  • TABLE 525 VOXCELL BIOINNOVATION INC.: COMPANY OVERVIEW
  • TABLE 526 PRODWAYS: COMPANY OVERVIEW
  • TABLE 527 INVENTIA LIFE SCIENCE PTY LTD.: COMPANY OVERVIEW
  • TABLE 528 UPNANO GMBH: COMPANY OVERVIEW
  • TABLE 529 UPM: COMPANY OVERVIEW
  • TABLE 530 TISSUELABS: COMPANY OVERVIEW
LIST OF FIGURES
 
  • FIGURE 1 3D BIOPRINTING MARKET: SEGMENTS COVERED
  • FIGURE 2 3D BIOPRINTING MARKET: REGIONS COVERED
  • FIGURE 3 RESEARCH DESIGN
  • FIGURE 4 BREAKDOWN OF PRIMARIES: 3D BIOPRINTING MARKET
  • FIGURE 5 3D BIOPRINTING MARKET SIZE ESTIMATION (SUPPLY SIDE ANALYSIS), 2023
  • FIGURE 6 MARKET SIZE ESTIMATION: COMPANY REVENUE ANALYSIS-BASED ESTIMATION, 2023
  • FIGURE 7 ILLUSTRATIVE EXAMPLE OF BICO GROUP AB: REVENUE SHARE ANALYSIS (2023)
  • FIGURE 8 MARKET VALIDATION FROM PRIMARY SOURCES
  • FIGURE 9 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
  • FIGURE 10 3D BIOPRINTING MARKET: CAGR PROJECTIONS, 2024–2029
  • FIGURE 11 DATA TRIANGULATION METHODOLOGY
  • FIGURE 12 3D BIOPRINTING MARKET, BY COMPONENT 2024 VS. 2029 (USD MILLION)
  • FIGURE 13 3D BIOPRINTING MARKET, BY APPLICATION, BY TYPE, 2024 VS. 2029 (USD MILLION)
  • FIGURE 14 3D BIOPRINTING MARKET, BY MATERIAL, 2024 VS. 2029 (USD MILLION)
  • FIGURE 15 3D BIOPRINTING MARKET, BY END USER, 2024 VS. 2029 (USD MILLION)
  • FIGURE 16 GEOGRAPHICAL SNAPSHOT OF 3D BIOPRINTING MARKET
  • FIGURE 17 RISING DEMAND FOR ORGAN TRANSPLANTS TO DRIVE MARKET
  • FIGURE 18 US AND 3D BIOPRINTERS ACCOUNTED FOR LARGEST MARKET SHARE IN 2023
  • FIGURE 19 3D BIOPRINTERS TO DOMINATE MARKET DURING STUDY PERIOD
  • FIGURE 20 ASIA PACIFIC COUNTRIES TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
  • FIGURE 21 3D BIOPRINTING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 22 NUMBER OF ORGAN TRANSPLANTS IN US (2024)
  • FIGURE 23 REVENUE SHIFT TOWARDS 3D BIOPRINTING COMPANIES
  • FIGURE 24 3D BIOPRINTING MARKET: VALUE CHAIN ANALYSIS
  • FIGURE 25 3D BIOPRINTING MARKET: SUPPLY CHAIN ANALYSIS
  • FIGURE 26 3D BIOPRINTING MARKET: ECOSYSTEM MAP
  • FIGURE 27 NUMBER OF PATENTS GRANTED ANNUALLY, 2014–2024
  • FIGURE 28 TOP TEN PLAYERS WITH HIGHEST NUMBER OF PATENT APPLICATIONS, 2014–2024
  • FIGURE 29 REGIONAL ANALYSIS OF PATENTS GRANTED, 2014–2024
  • FIGURE 30 3D BIOPRINTING MARKET: PORTER’S FIVE FORCES ANALYSIS
  • FIGURE 31 NORTH AMERICA: 3D BIOPRINTING MARKET SNAPSHOT
  • FIGURE 32 ASIA PACIFIC: 3D BIOPRINTING MARKET SNAPSHOT
  • FIGURE 33 3D BIOPRINTING MARKET: STRATEGIES ADOPTED
  • FIGURE 34 REVENUE ANALYSIS OF KEY PLAYERS (2021–2023)
  • FIGURE 35 MARKET SHARE ANALYSIS OF KEY PLAYERS (2023)
  • FIGURE 36 3D BIOPRINTING MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
  • FIGURE 37 3D BIOPRINTING MARKET: OVERALL FOOTPRINT
  • FIGURE 38 3D BIOPRINTING MARKET: COMPANY EVALUATION MATRIX (START-UPS/SMES), 2023
  • FIGURE 39 EV/EBITDA OF KEY VENDORS
  • FIGURE 40 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
  • FIGURE 41 3D BIOPRINTING MARKET: BRAND/PRODUCT COMPARISON
  • FIGURE 42 BICO GROUP AB: COMPANY SNAPSHOT (2023)
  • FIGURE 43 3D SYSTEMS, INC.: COMPANY SNAPSHOT (2022)
  • FIGURE 44 MERCK KGAA: COMPANY SNAPSHOT (2023)
  • FIGURE 45 ORGANOVO HOLDINGS INC.: COMPANY SNAPSHOT (2023)
  • FIGURE 46 COLLPLANT BIOTECHNOLOGIES LTD.: COMPANY SNAPSHOT (2023)

This study involved four major activities in estimating the current size of the 3D bioprinting market. Exhaustive secondary research was carried out to collect information on the market, its peer markets, and its parent market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation procedures were used to estimate the market size of segments and subsegments.

Secondary Research

Secondary research was used mainly to identify and collect information for the extensive technical, market-oriented, and commercial study of the 3D bioprinting market. The secondary sources used for this study include World Health Organization (WHO), Food and Drug Administration (US), National Health Service (NHS), ClinicalTrials.Gov, National Institutes of Health (NIH), Elsevier, Canadian Manufacturers & Exporters (CME) , Ministry of Science and Technology (China), Dubai Health Authority (DHA), South African Department of Science and Technology (DST), Ministry of Food and Drug Safety (South Korea), Organ Procurement and Transplantation Network (OPTN), OrganDonor.gov, Eurotransplant (ET), Centre for Commercialization of Regenerative Medicine (CCRM), Networks of Centres of Excellence (NCE), Human Tissue Authority (HTA), Human Fertilisation and Embryology Authority (HFEA), Medicines and Healthcare Products Regulatory Agency (MHRA), Advanced Research Projects Agency for Health (ARPA-H), American Public Health Association (APHA), American Public Health Association (APHA), National Kidney Foundation (NKF), National University Centre for Organ Transplantation (NUCOT), ACS Journals; Corporate filings such as annual reports, SEC filings, investor presentations, and financial statements; research journals; press releases; and trade, business, and professional associations. Secondary data was collected and analyzed to arrive at the overall size of the global 3D bioprinting market, which was validated through primary research.

Primary Research

In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, among other experts, to obtain and verify the critical qualitative and quantitative information as well as assess future prospects of the market. Various primary sources from both the supply and demand sides of the market were interviewed to obtain qualitative and quantitative information. The following is a breakdown of the primary respondents:

3D bioprinting Market Size, and Share

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

The global size of the 3D bioprinting market was estimated through multiple approaches. A detailed market estimation approach was followed to estimate and validate the value of the market and other dependent submarkets. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

  • The major players in the industry and market have been identified through extensive primary and secondary research.
  • The revenues generated from the 3D bioprinting business of players operating in the market have been determined through secondary research and primary analysis.
  • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.

Global 3D bioprinting Market Size: Bottom-Up Approach

3D bioprinting Market Size, and Share

To know about the assumptions considered for the study, Request for Free Sample Report

Top-down Approach-

3D bioprinting Market Size, and Share

Data Triangulation

After estimating the overall market size from the market size estimation process, the total market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.

Market Definition

Bioprinting is a technology where bioinks and biomaterials, mixed with cells, are 3D printed, often to construct living tissue models. Bioprinting, in general, is defined as the deposition of living cells in combination with biological substances, such as collagen, fibrin, and gelatin, for the growth of complete tissues and organs. The 3D bioprinting process starts with the creation of an architectural design that is based on the fundamental composition of the organs or target tissues and makes use of living cells, molecules, and biomaterials to produce complex living and non-living biological products.

Key Stakeholders

  • Academic Research Institutes
  • Pharmaceutical & Biotechnology Companies
  • Life Science Companies
  • Venture Capitalists and Investors
  • Government Organizations
  • Private Research Firms
  • Contract Research Organizations (CROs)
  • Contract Development and Manufacturing Organizations (CDMOs)
  • Research and Development (R&D) Companies
  • 3D Cell Culture Product Manufacturers

Report Objectives

  • To define, describe, and forecast the 3D bioprinting market based on component, material, application, end user, and region
  • To provide detailed information regarding the major factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
  • To analyze micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall 3D Bioprinting market
  • To analyze the opportunities for stakeholders and provide details of the competitive landscape for market leaders
  • To forecast the market size of the segments with respect to six regions: North America, Europe, Asia Pacific, Latin America, Middle East, and Africa
  • To profile the key players and analyze their market shares and core competencies2
  • To track and analyze competitive developments, such as acquisitions, product launches, expansions, agreements, partnerships, and collaborations
  • To benchmark players within the market using the proprietary “Company Evaluation Matrix” framework, which analyzes market players on various parameters within the broad categories of business and product excellence strategies, including trends/disruptions impacting customers’ business, pricing analysis, supply/value chain analysis, ecosystem analysis, technology analysis, patent analysis, trade analysis, key conferences & events in 2024-2025, key stakeholders & buying criteria, and investment & funding scenario.

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for this report:

Product Analysis

  • Product matrix, which provides a detailed comparison of the product portfolio of each company in the 3D bioprinting Market
Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Request Customization

Instant Answers with GPT - Ask Now!

Ask real questions. Get complete answers !
Report Code
BT 4971
Published ON
May, 2024
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the 3D Bioprinting Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
knowledgestore logo

Hold On!

Want to explore hidden markets that can drive new revenue in 3D Bioprinting Market?

Find Hidden Markets
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2024 MarketsandMarkets Research Private Ltd. All rights reserved
DMCA.com Protection Status
Website Feedback